• Je něco špatně v tomto záznamu ?

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN

JY. Blay, P. Casali, C. Bouvier, C. Dehais, I. Galloway, J. Gietema, J. Halámková, N. Hindi, A. Idbaih, E. Kinloch, HJ. Klümpen, T. Kolarova, K. Kopeckova, J. Lovey, M. Magalhaes, K. Oselin, S. Piperno-Neumann, A. Ravnsbaek, M. Rogasik, A....

. 2021 ; 6 (4) : 100174. [pub] 20210615

Jazyk angličtina Země Velká Británie

Typ dokumentu zprávy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003992

Department of Chemotherapy Clinic of Haematology and Oncology North Estonia Medical Centre Foundation Tallinn Estonia

Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic

Department of Medical Oncology Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

Department of Medical Oncology Centre Leon Berard and Centre de Recherche en Cancérologie de Lyon and Université Claude Bernard Lyon 1 Lyon France

Department of Medical Oncology Charing Cross Hospital Campus of Imperial College London London UK

Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan Milan Italy

Department of Medical Oncology University Medical Centre Groningen Groningen The Netherlands

Department of Oncology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

EURORDIS Rare Diseases Europe

Institute of Biomedicine of Sevilla Virgen Virgen del Rocío University Hospital Seville Spain

International Neuroendocrine Cancer Alliance Boston USA

Lithuanian University of Health Sciences Department of Neurosurgery Kaunas Lithuania

Maria Skłodowska Curie Institute Warsaw Poland

Medical Oncology Department Institut Curie Paris France

Medical University of Graz Graz Austria

Melanoma Patient Network Europe OcuMel Birmingham UK

National Institute of Oncology Budapest Hungary

Neuroendocrine Cancer Unit Royal Free Hospital London UK

Oncology Department and Danish Centre for Particle Therapy University Hospital Aarhus Denmark

Oncology Department Centro Hospitalar e Universitário Universitário do Porto Porto Portugal

Research and Innovation Department Centre Léon Bérard Lyon France

Salivary Gland Cancer London UK

Sarcoma Patient EuroNet

Sorbonne Université Inserm CNRS UMR S 1127 Institut du Cerveau ICM AP HP Hôpitaux Universitaires La Pitié Salpêtrière Charles Foix Service de Neurologie 2 Mazarin Paris France

Thyroid Cancer Alliance Rotterdam The Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003992
003      
CZ-PrNML
005      
20220127145645.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.esmoop.2021.100174 $2 doi
035    __
$a (PubMed)34139485
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Blay, J-Y $u Department of Medical Oncology, Centre Leon Berard & Centre de Recherche en Cancérologie de Lyon (CRCL) & Université Claude Bernard Lyon 1, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr
245    10
$a European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN / $c JY. Blay, P. Casali, C. Bouvier, C. Dehais, I. Galloway, J. Gietema, J. Halámková, N. Hindi, A. Idbaih, E. Kinloch, HJ. Klümpen, T. Kolarova, K. Kopeckova, J. Lovey, M. Magalhaes, K. Oselin, S. Piperno-Neumann, A. Ravnsbaek, M. Rogasik, A. Safwat, S. Scheipl, M. Seckl, J. Taylor, M. Temnyk, A. Trama, M. Urbonas, M. Wartenberg, A. Weinman, EURACAN Network
650    _2
$a poskytování zdravotní péče $7 D003695
650    _2
$a lidé $7 D006801
650    12
$a nádory $x terapie $7 D009369
650    _2
$a vzácné nemoci $7 D035583
655    _2
$a zprávy $7 D016433
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Casali, P $u Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy
700    1_
$a Bouvier, C $u Neuroendocrine Cancer Unit, Royal Free Hospital, London, UK
700    1_
$a Dehais, C $u Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France
700    1_
$a Galloway, I $u Melanoma Patient Network Europe, OcuMel, Birmingham, UK
700    1_
$a Gietema, J $u Department of Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands
700    1_
$a Halámková, J $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Hindi, N $u Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Virgen, Virgen del Rocío University Hospital, Seville, Spain
700    1_
$a Idbaih, A $u Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France
700    1_
$a Kinloch, E $u Salivary Gland Cancer, London, UK
700    1_
$a Klümpen, H-J $u Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Kolarova, T $u International Neuroendocrine Cancer Alliance, Boston, USA
700    1_
$a Kopeckova, K $u Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Lovey, J $u National Institute of Oncology, Budapest, Hungary
700    1_
$a Magalhaes, M $u Oncology Department, Centro Hospitalar e Universitário Universitário do Porto, Porto, Portugal
700    1_
$a Oselin, K $u Department of Chemotherapy, Clinic of Haematology and Oncology, North Estonia Medical Centre Foundation, Tallinn, Estonia
700    1_
$a Piperno-Neumann, S $u Medical Oncology Department, Institut Curie, Paris, France
700    1_
$a Ravnsbaek, A $u Oncology Department, and Danish Centre for Particle Therapy, University Hospital, Aarhus, Denmark
700    1_
$a Rogasik, M $u Research and Innovation Department, Centre Léon Bérard, Lyon, France
700    1_
$a Safwat, A $u Oncology Department, and Danish Centre for Particle Therapy, University Hospital, Aarhus, Denmark
700    1_
$a Scheipl, S $u Medical University of Graz, Graz, Austria
700    1_
$a Seckl, M $u Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK
700    1_
$a Taylor, J $u Thyroid Cancer Alliance, Rotterdam, The Netherlands
700    1_
$a Temnyk, M $u Maria Skłodowska Curie Institute, Warsaw, Poland
700    1_
$a Trama, A $u Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy
700    1_
$a Urbonas, M $u Lithuanian University of Health Sciences, Department of Neurosurgery, Kaunas, Lithuania
700    1_
$a Wartenberg, M $u Sarcoma Patient EuroNet
700    1_
$a Weinman, A $u EURORDIS-Rare Diseases Europe (European Patient Organisation for Rare Diseases)
710    2_
$a EURACAN Network
773    0_
$w MED00196632 $t ESMO open $x 2059-7029 $g Roč. 6, č. 4 (2021), s. 100174
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34139485 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145641 $b ABA008
999    __
$a ok $b bmc $g 1751452 $s 1155141
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 6 $c 4 $d 100174 $e 20210615 $i 2059-7029 $m ESMO open $n ESMO Open $x MED00196632
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...